A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis

• Status: Completed
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and effectiveness of two concentrations of IDP-108 in treating patients with onychomycosis

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dow Pharmaceutical Sciences

Criteria

Inclusion Criteria:

• Presence of onychomycosis of the target toenail

• A positive fungal culture from the target toenail

Exclusion Criteria:

• Any disease or condition that might cause nail abnormalities or may interfere with clinical evaluations

• Presence of tinea pedis (athletes foot)

• Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study